CXO+医疗耗材+ AI医疗多板块爆发，医疗器械ETF（159883）和港股医疗ETF（159366）连续上涨

Core Viewpoint - The medical device sector is experiencing significant growth driven by the explosion in CXO, medical consumables, and AI medical segments, leading to a notable increase in the performance of related ETFs [1][2][3]. Group 1: ETF Performance - The medical device ETF (159883) opened high and rose by 0.96% during the early session, with a peak increase of nearly 2%, marking an attempt for an eight-day consecutive rise [1]. - As of July 24, the medical device ETF (159883) had a net subscription of 180 million shares in the early session, with a total circulation of 4.762 billion shares, reflecting an increase of nearly 1 billion shares over the past month [1]. - The latest circulation scale of the medical device ETF (159883) reached 2.466 billion yuan, making it the largest medical device ETF product among Wind industry ETFs [1]. Group 2: Policy and Market Dynamics - The Hong Kong medical ETF (159366) saw a rise of 2.08% in early trading, with an intraday peak exceeding 4%, indicating a potential three-day consecutive increase [2]. - The National Medical Insurance Administration recently held a seminar to discuss new measures for supporting innovative drugs and medical devices, including the establishment of new medical service pricing projects and encouraging the global development of Chinese innovative drugs and devices [2]. - The latest round of national drug procurement has started, with new rules being optimized to reduce reliance on minimum pricing, which is expected to alleviate competitive pressure in the high-value consumables sector [2][3]. Group 3: Sector Outlook - Analysts from Ping An Securities suggest that the high-value consumables sector may benefit from favorable policy expectations, with ongoing optimization of procurement policies expected to reduce valuation pressure [3]. - Huatai Securities indicates that the pressure from the US interest rate hike cycle on new drug financing is gradually easing, leading to a recovery in overseas new drug research and development demand, which is beneficial for Chinese companies [3]. - The medical device ETF (159883) tracks the CSI All-Index Medical Device Index, covering various sub-sectors such as medical equipment, consumables, and in vitro diagnostics, positioning it as a key player in the market [3].